FN2 Research
Markets, explained.
Cited, no-noise breakdowns of why stocks move — earnings reactions, macro shifts, and the data behind the headlines.
Three Fronts at Once: Polysilicon Tariffs, Hormuz Ceasefire, and Taiwan Drills Hit Markets on the Same Week
The US extended its tech war into polysilicon with a 15% tariff, a two-week Iran ceasefire kept oil volatile near $82, and Chinese coast guard drills east of Taiwan signaled a trade quarantine rehearsal — all in the same week the Dow snapped a five-day win streak as oil and yields rose together.
When Record Profits Meet a Resurgent Oil Risk Premium
Q2 earnings growth of 47.4% pushed the S&P 500 to a record close above 7,700, but a Thursday breather led by the Dow's 464-point drop shows investors repricing Iran-Hormuz oil risk. Pre-market Friday, QQQ is quietly bouncing.
SpaceX Unlock Defies Gravity: What $100 Billion in Freed Shares Means for the IPO Pipeline
SpaceX's first post-IPO lockup expiration freed roughly $100 billion in insider shares on August 6, more than doubling the public float. The stock rose 6% instead of cratering. The staggered unlock schedule and the broader IPO pipeline — Anthropic, Braveheart Bio, Jersey Mike's — now hang on whether that calm holds.
Hormuz Deal Optimism Meets a Tanker Freeze: The Widening Gap Between Oil Prices and Physical Reality
Oil markets are pricing a Hormuz reopening that hasn't materialized in tanker traffic. Near-zero transits, a Houthi blockade of the alternative route, and fresh China trade retaliation create a fragile setup where any diplomatic setback could snap prices back sharply.
Oil, Yields, and AI: The Market Is Trading Two Stories at Once
XLE's 1.5% gain on Iran-driven oil strength is the cleanest tell in Thursday's tape. Rising Treasury yields are pressuring rate-sensitive financials — Goldman Sachs fell 2.6% — while Microsoft's post-earnings momentum and Eli Lilly's GLP-1 surge keep the AI and healthcare narratives alive. Tomorrow's nonfarm payrolls is the next catalyst.
SpaceX Lockup Test: 911 Million Shares Unlock as IPO Pipeline Surges and Reg NMS Faces Rescission
SpaceX's first lockup expiry frees up to 911.5 million insider shares on August 6, potentially tripling the public float of a stock already down 49% from its June high. The test arrives as biotech IPOs accelerate, July saw $29.3 billion in new listings, and the SEC moves to rescind Regulation NMS's trade-through rule.
AI Earnings Reset Meets a Hormuz Reversal: The Market's Split Close
The S&P 500 slipped 0.15% as four AI-linked stocks shed roughly $68 billion in market value despite earnings beats, while energy surged on Brent's jump after Iran published restrictive Strait of Hormuz transit terms. Microsoft's $90 billion quarter offered a counter-narrative, and Friday's payrolls loom.
SpaceX Lockup Test Meets Biotech IPO Pipeline as SEC Rewrites Market Plumbing
SpaceX's first lockup expiry could more than double the public float on August 6. The August IPO calendar is biotech-heavy. And the SEC's proposed rescission of Reg NMS Rules 611 and 610(e) represents the most significant equity market-structure change in two decades.
Two-Front Geopolitical Crossroads: Hormuz De-escalation Meets China's Broadest Retaliation Since the Truce
Markets are pricing a Hormuz peace dividend while China escalates the tech war and the first joint yen intervention since 1998 flags quiet currency stress. The crossroads is whether de-escalation in one theater offsets escalation in another.
Records Hold, Memory Chips Crack: A Market Testing Its Seams
Markets paused near record highs on Thursday as memory stocks cracked on weak guidance despite earnings beats, a potential Strait of Hormuz agreement sent energy and gold higher, and jobless claims came in below expectations — a tape pulled in three directions at once.
A Supply Tsunami Hits US Markets: SpaceX Lockup Unlocks $101B While $5B in Follow-Ons Price
SpaceX's first lockup expiration frees 911 million shares—more than doubling the float—in the same week that Prologis, Celestica, and Twist Bioscience tap equity markets for over $5 billion combined. The market's ability to digest this supply wave is the real test.
Hormuz Deal Hopes Deflate Oil's War Premium — But Three Fronts Keep Risk Bidding
Oil's geopolitical risk premium deflated this week as Iran and Oman reached the final stage of a Strait of Hormuz reopening framework, sending Brent down 5% and dragging oil majors and refiners lower. But Houthi Red Sea attacks on Saudi tankers, Ukraine's escalating drone campaign against Russian refineries, and China's extended coast guard patrols east of Taiwan are keeping the geopolitical risk bid alive — gold surged 4% even as oil fell.